TLR9-IN-3 is a TLR9 antagonist with an IC50 of 0.4 µM. TLR9-IN-3 shows selectivity for TLR4 and TLR8, and inhibits CD69 activation in human whole blood with a corresponding IC50 of 1.1 µM. TLR9-IN-3 can be used in research related to pulmonary fibrosis[1].
Molecular Weight:
356.47
CAS Number:
[2903190-66-7]
Formula:
C18H28N8
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted